摘要
Antibiotics can be divided into various groups, each containing a characteristic structural part common to antibiotics of the same group.Ageneandgeneset, involved in the biosynthesis of a characteristic structural part is shown by chemical structures of antibiotics to be widely distributed among various strains of microorganisms.On the basis of this fact, genetics of microbial secondary metabolites was studied and the reason why various compounds were produced by microorganisms was elucidated.On the basis of the fact that microorganisms produce various compounds, the author searched for compounds which bound to the cell surface, that is, he searched for inhibitors of enzymes on the cellular surface and was successful in finding immunomodulators.Mechanisms of actions and toxicities of useful antibiotics and enzyme inhibitors suchfas arninoglycoside antibiotics, bleomycins, bestatin etc. were studied in relation to their structures, and on the basis of their results, more effective useful derivatives qf them were synthesized and successful results were obtained.Microbial products were shown to be one of the most important areas of application in organic chemistry to develop bioactive compounds useful in the treatment of diseases.The screening of bioactive microbial products provided chemists with interesting materials for the structure studies and the design of new chemical syntheses, and the results of these studies promoted the progress of the study on structure-activ-~t y relationships.Moreover, the study of genetics and biosyntheses of microbial products began with their structures.In these studies, the author endeavoured to open up new research areas where new useful bioactive compounds were discovered and new principles were explored.In 1953, the author extended the study of antimicrobial antibiotics to the study of antitumor antibiotics, reporting the findings of two new microbial products which inhibited the growth of experimental animal tumors1'* and in 1967, the author extended the study of antibiotics to small molecular enzyme inhibitor^.^Up to now, the author has found more than 40 new enzyme inhibitors.These small molecular enzyme inhibitors have no antimicrobial activity.Findings of enzyme inhibitors and antibiotics indicate that microorganisms produce various compounds which have widely varied structures.This led the author to the study of their genetics.Microbial secondary metabolites have been defined to be the microbial products which have no function in the growth of microbial cells.Recently the author extended the study of enzyme inhibitors to those which enhanced immune responses.These compounds have potential usefulness in the treatment of cancer and resistant infections.On the other hand, the author was successful in the elucidation of enzymic mechanisms of resistance to aminoglycosidic antibiotics in 1967 which opened up a fruitful research area where the derivatives active against resistant infections were developed.The study of bioactive microbial products is one of the most important areas of application in organic chemistry.In other words, chemistry is the fundamental science of biological and medical sciences and it may be expressed in the future completely in chemical terms.At present, chemical studies of bioactive microbial products still continue to discover the active agents useful in the treatment of diseases difficult to cure.It is also interesting that-almost all bioactive microbial secondary metabolites contain oxygen or nitrogen, or both of them.In this paper, the author describes his recent studies on genetics of bioactive microbial products, active structures and development of compounds with potential usefulness.